Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma

[1]  Jianguo Wen,et al.  Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China , 2019, BMC Urology.

[2]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[3]  T. Klatte,et al.  Prognostic factors and prognostic models for renal cell carcinoma: a literature review , 2018, World Journal of Urology.

[4]  C. Kwak,et al.  Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis , 2017, Clinical genitourinary cancer.

[5]  R. Autorino,et al.  Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta‐analysis , 2017, BJU international.

[6]  A. Harraz,et al.  Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience , 2017, Arab journal of urology.

[7]  Xuesong Li,et al.  The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy , 2016, BioMed research international.

[8]  B. Hadaschik,et al.  Local Recurrence After Curative Surgical Treatment of Renal Cell Cancer: A Study of 91 Patients. , 2016, Clinical genitourinary cancer.

[9]  Y. Kaiho,et al.  Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2016, International journal of urology : official journal of the Japanese Urological Association.

[10]  K. Bensalah,et al.  Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis , 2014, BJU international.

[11]  Liangren Liu,et al.  Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis. , 2014, Urologic oncology.

[12]  M. Jinzaki,et al.  Independent Predictors for Bladder Outcomes after Treatment of Intravesical Recurrence following Radical Nephroureterectomy in Patients with Primary Upper Tract Urothelial Carcinoma , 2014, Annals of Surgical Oncology.

[13]  F. Montorsi,et al.  Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. , 2014, European urology.

[14]  M. Peyromaure,et al.  Bladder recurrence after radical nephroureterectomy: Predictors and impact on oncological outcomes , 2013, International journal of urology : official journal of the Japanese Urological Association.

[15]  K. Moon,et al.  External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2013, British Journal of Cancer.

[16]  K. Bensalah,et al.  Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. , 2013, The Journal of urology.

[17]  K. Bensalah,et al.  Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. , 2012, European urology.

[18]  K. Bensalah,et al.  Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. , 2012, Urologic oncology.

[19]  C. Kwak,et al.  Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. , 2011, Urologic oncology.

[20]  O. Cussenot,et al.  Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. , 2011, Urologic oncology.

[21]  Liang Cheng,et al.  Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis , 2005, Clinical Cancer Research.

[22]  M. Kattan,et al.  Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. , 2004, The Journal of urology.

[23]  R. Takahashi,et al.  Metachronous multifocal development of urothelial cancers by intraluminal seeding , 1993, The Lancet.

[24]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.